RhumbLine Advisers
HURA

RhumbLine Advisers’s TuHURA Biosciences HURA Stock Holding History

RhumbLine Advisers’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.1K Sell
20,730
-2,868
-12% -$3.52K ﹤0.01% 3643
2025
Q4 		$17.9K Buy
23,598
+1,663
+8% +$3.18K ﹤0.01% 3777
2025
Q3 		$54.4K Sell
21,935
-2,841
-11% -$7.48K ﹤0.01% 3643
2025
Q2 		$55.2K Buy
+24,776
New +$83.7K ﹤0.01% 3656

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

RhumbLine Advisers's HURA Position: Q1 2026 in Review

RhumbLine Advisers reduced its TuHURA Biosciences (HURA) stake by 12% in Q1 2026, selling an estimated $3.52K and leaving 20,730 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

RhumbLine Advisers first reported a position in HURA in Q2 2025 and has held it in 4 quarters since. The position peaked at $55.2K in Q2 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • RhumbLine Advisers held 20,730 shares of TuHURA Biosciences worth $37.1K as of Q1 2026.
  • RhumbLine Advisers sold 2,868 TuHURA Biosciences shares in Q1 2026, an estimated $3.52K.
  • TuHURA Biosciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3643 holding.
  • RhumbLine Advisers first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 4 quarters since.
  • RhumbLine Advisers's TuHURA Biosciences position peaked at $55.2K in Q2 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.